Drug Induced Movement Disorders / Edition 2by Stewart Factor
Pub. Date: 02/21/2005
An invaluable addition to the library of any neurologist, this book updates and presents the current state of the art clinical approaches to this subject, assisting neurologists and physicians alike in this difficult but increasingly common situation. See more details below
An invaluable addition to the library of any neurologist, this book updates and presents the current state of the art clinical approaches to this subject, assisting neurologists and physicians alike in this difficult but increasingly common situation.
- Publication date:
- Edition description:
- Product dimensions:
- 6.30(w) x 9.30(h) x 1.30(d)
Table of Contents
Section 1: General Considerations.
Chapter 1: Movement Disorders: Approach, Definitions and differential Diagnosis.
Martin Cloutier, Anthony E. Lang.
Chapter 2: Rating Scales for Movement Disorders.
Wonodi I, Hong EH, Avila MT, Gunvant Thaker.
Chapter 3: Spontaneous movement disorders in psychiatric patients.
Irene Richard, Christopher O’Brien, Roger Kurlan.
Section 2: Antipsychotics.
Chapter 4: Pharmacology of typical and atypical agents.
Gary Remington, Shitij Kapur.
Chapter 5: Acute Drug-induced Dystonia.
Michael F. Mazurek, Patricia I. Rosebush.
Chapter 6: Drug-Induced Parkinsonism.
Joseph H. Friedman, Martha E. Trieschmann, Hubert H. Fernandez.
Chapter 7: Acute Akathisia.
Author: Lenard A. Adler, John Rotrosen, Burt Angrist.
Chapter 8: Neuroleptic Malignant Syndrome.
Stewart A. Factor.
Chapter 9: Classical Tardive Dyskinesia.
Thomas M. Hyde, MD, Jose A. Apud, Whitney C. Fisher, Michael F. Egan.
Chapter 10: Tardive dyskinesia Variants.
Skidmore F, Weiner W, Burke R.
Chapter 11: Movement Disorders caused by atypical antipsychotics.
Karen E. Anderson.
Chapter 12: Commentary: Is Tardive dyskinesia disappearing?James Lohr, MD.
Section 3: Dopaminomimetic Drugs.
Chapter 13: Dyskinesia induced by levodopa and dopamine agonists in Parkinson’s disease.
John G. Nutt, Matthew Brodsky.
Chapter 14: Stimulant Drugs.
Anthony E. Munson, Juan Sanchez-Ramos, William J Weiner.
Section 5: Other Drugs.
Chapter 15: Antidepressants.
Marie L. Moro-de-Casillas, David E. Riley.
Chapter 16: Anticonvulsants.
John C. Morgan, Madeline Harrison.
Chapter 17: Miscellaneous Drugs.
and post it to your social network
Most Helpful Customer Reviews
See all customer reviews >